Aqr Capital Management LLC Gt Biopharma, Inc. Transaction History

Aqr Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.64 - $3.11 $21,101 - $40,016	-12,867 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.6 - $3.3 $42,647 - $54,129	-16,403 Reduced 56.04%	12,867 $37,000
Q4 2021 Feb 14, 2022	BUY	$3.05 - $7.08 $37,499 - $87,048	12,295 Added 72.43%	29,270 $89,000
Q3 2021 Nov 15, 2021	BUY	$6.68 - $15.26 $113,393 - $259,038	16,975 New	16,975 $114,000

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $96.4M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.